Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
Multiples is the first private equity (PE) investor in the company
They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights
It is developing the drug candidate to potentially treat immunological diseases
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
Subscribe To Our Newsletter & Stay Updated
